152 related articles for article (PubMed ID: 15707670)
21. Regional distribution to recovery of 5-HT levels after administration of "atrophins" MDMA and D,L-fenfluramine. Stereospecificity and comparison with 5,7-dihydroxytryptamine.
Lehmann J; DeSouza EB; Culp S; Zaczek R
Ann N Y Acad Sci; 1992 May; 648():291-5. PubMed ID: 1379013
[No Abstract] [Full Text] [Related]
22. Differential effects of d-fenfluramine and p-chloroamphetamine on H75/12-induced depletion of 5-hydroxytryptamine and dopamine in the rat brain.
Fattaccini CM; Gozlan H; Hamon M
Neuropharmacology; 1991 Jan; 30(1):15-23. PubMed ID: 1710793
[TBL] [Abstract][Full Text] [Related]
23. RETRACTED: Severe dopaminergic neurotoxicity in primates after a common recreational dose regimen of MDMA ("ecstasy").
Ricaurte GA; Yuan J; Hatzidimitriou G; Cord BJ; McCann UD
Science; 2002 Sep; 297(5590):2260-3. PubMed ID: 12351788
[TBL] [Abstract][Full Text] [Related]
24. Caffeine promotes hyperthermia and serotonergic loss following co-administration of the substituted amphetamines, MDMA ("Ecstasy") and MDA ("Love").
McNamara R; Kerans A; O'Neill B; Harkin A
Neuropharmacology; 2006 Jan; 50(1):69-80. PubMed ID: 16188283
[TBL] [Abstract][Full Text] [Related]
25. The acute effects of amphetamine derivatives on extracellular serotonin and dopamine levels in rat nucleus accumbens.
Kankaanpää A; Meririnne E; Lillsunde P; Seppälä T
Pharmacol Biochem Behav; 1998 Apr; 59(4):1003-9. PubMed ID: 9586861
[TBL] [Abstract][Full Text] [Related]
26. Antagonism of 3,4-methylenedioxymethamphetamine-induced neurotoxicity in rat brain by 1-piperonylpiperazine.
Hashimoto K; Maeda H; Goromaru T
Eur J Pharmacol; 1992 Sep; 228(2-3):171-4. PubMed ID: 1280228
[TBL] [Abstract][Full Text] [Related]
27. Effects of subchronic exposure to styrene on the extracellular and tissue levels of dopamine, serotonin and their metabolites in rat brain.
Gagnaire F; Chalansonnet M; Carabin N; Micillino JC
Arch Toxicol; 2006 Oct; 80(10):703-12. PubMed ID: 16518643
[TBL] [Abstract][Full Text] [Related]
28. Changes in dopamine, serotonin and their metabolites in discrete brain areas of rat offspring after in utero exposure to cocaine or related drugs.
Henderson MG; McMillen BA
Teratology; 1993 Nov; 48(5):421-30. PubMed ID: 7508151
[TBL] [Abstract][Full Text] [Related]
29. Effects of prenatal exposure to styrene on neurochemical levels in rat brain.
Katakura Y; Kishi R; Ikeda T; Miyake H
Toxicol Lett; 1999 Apr; 105(3):239-49. PubMed ID: 10355545
[TBL] [Abstract][Full Text] [Related]
30. Reduced efficacy of fluoxetine following MDMA ("Ecstasy")-induced serotonin loss in rats.
Durkin S; Prendergast A; Harkin A
Prog Neuropsychopharmacol Biol Psychiatry; 2008 Dec; 32(8):1894-901. PubMed ID: 18824064
[TBL] [Abstract][Full Text] [Related]
31. Behavioural, hyperthermic and neurotoxic effects of 3,4-methylenedioxymethamphetamine analogues in the Wistar rat.
O'Loinsigh ED; Boland G; Kelly JP; O'Boyle KM
Prog Neuropsychopharmacol Biol Psychiatry; 2001 Apr; 25(3):621-38. PubMed ID: 11371001
[TBL] [Abstract][Full Text] [Related]
32. Neurochemical and Neurotoxic Effects of MDMA (Ecstasy) and Caffeine After Chronic Combined Administration in Mice.
Górska AM; Kamińska K; Wawrzczak-Bargieła A; Costa G; Morelli M; Przewłocki R; Kreiner G; Gołembiowska K
Neurotox Res; 2018 Apr; 33(3):532-548. PubMed ID: 29134560
[TBL] [Abstract][Full Text] [Related]
33. Repeated administration of the substituted amphetamine p-methoxyamphetamine produces reductions in cortical 5-HT transporter binding but not 5-HT content, unlike 3,4-methylenedioxyamethamphetamine.
Callaghan PD; Farrand K; Salem A; Hughes P; Daws LC; Irvine RJ
Eur J Pharmacol; 2006 Sep; 546(1-3):74-81. PubMed ID: 16925993
[TBL] [Abstract][Full Text] [Related]
34. Behavioral and neurochemical effects of prenatal methylenedioxymethamphetamine (MDMA) exposure in rats.
St Omer VE; Ali SF; Holson RR; Duhart HM; Scalzo FM; Slikker W
Neurotoxicol Teratol; 1991; 13(1):13-20. PubMed ID: 1710762
[TBL] [Abstract][Full Text] [Related]
35. Neonatal 3,4-methylenedioxymethamphetamine (MDMA) exposure alters neuronal protein kinase A activity, serotonin and dopamine content, and [35S]GTPgammaS binding in adult rats.
Crawford CA; Williams MT; Kohutek JL; Choi FY; Yoshida ST; McDougall SA; Vorhees CV
Brain Res; 2006 Mar; 1077(1):178-86. PubMed ID: 16483555
[TBL] [Abstract][Full Text] [Related]
36. 2-Deoxy-D-glucose prevents and nicotinamide potentiates 3, 4-methylenedioxymethamphetamine-induced serotonin neurotoxicity.
Hervías I; Lasheras B; Aguirre N
J Neurochem; 2000 Sep; 75(3):982-90. PubMed ID: 10936179
[TBL] [Abstract][Full Text] [Related]
37. Methamphetamine neurotoxicity and striatal glutamate release: comparison to 3,4-methylenedioxymethamphetamine.
Nash JF; Yamamoto BK
Brain Res; 1992 May; 581(2):237-43. PubMed ID: 1356579
[TBL] [Abstract][Full Text] [Related]
38. Behavioural and neurochemical effects induced by chronic mild stress applied to two different rat strains.
Bekris S; Antoniou K; Daskas S; Papadopoulou-Daifoti Z
Behav Brain Res; 2005 Jun; 161(1):45-59. PubMed ID: 15904709
[TBL] [Abstract][Full Text] [Related]
39. Dopaminergic regulation of the serotonergic raphe-striatal pathway: microdialysis studies in freely moving rats.
Ferré S; Cortés R; Artigas F
J Neurosci; 1994 Aug; 14(8):4839-46. PubMed ID: 7519257
[TBL] [Abstract][Full Text] [Related]
40. Effect of repeated ('binge') dosing of MDMA to rats housed at normal and high temperature on neurotoxic damage to cerebral 5-HT and dopamine neurones.
Sanchez V; O'shea E; Saadat KS; Elliott JM; Colado MI; Green AR
J Psychopharmacol; 2004 Sep; 18(3):412-6. PubMed ID: 15358986
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
